CODEXIS INC. - COMMON STOCK

Codexis Reports Fourth Quarter and Fiscal Year 2021 Financial Results

24 фев 2022 16:05:01 Источник Nasdaq GlobeNewswire

Codexis to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 24

10 фев 2022 16:05:00 Источник Nasdaq GlobeNewswire

Codexis Announces FDA Orphan Drug and Rare Pediatric Disease Designations for CDX 6512 for the Treatment of Homocystinuria

24 янв 2022 08:00:00 Источник Nasdaq GlobeNewswire

Codexis to Participate in the H.C. Wainwright Virtual BioConnect Conference

05 янв 2022 08:00:02 Источник Nasdaq GlobeNewswire

Codexis Launches Codex® HiTemp Reverse Transcriptase to Address Key Challenges in One-Step Assays for RNA Detection in PCR Testing, including COVID-19 Testing

15 дек 2021 08:00:01 Источник Nasdaq GlobeNewswire

Codexis Presents Pre-Clinical Data Highlighting its Programs in Homocystinuria and Maple Syrup Urine Disease at ICIEM 2021

22 ноя 2021 08:00:02 Источник Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Virtual Healthcare Conferences

19 ноя 2021 08:00:00 Источник Nasdaq GlobeNewswire

Codexis Appoints Two New Senior Leaders for Human Resources and Corporate Development

15 ноя 2021 08:00:03 Источник Nasdaq GlobeNewswire

Codexis to Present Data Highlighting Two New Therapeutic Discovery Programs at the 14th International Congress of Inborn Errors of Metabolism 2021

15 ноя 2021 08:00:03 Источник Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Virtual Healthcare Conferences

09 ноя 2021 16:05:00 Источник Nasdaq GlobeNewswire

Codexis Reports Third Quarter 2021 Financial Results

04 ноя 2021 16:05:02 Источник Nasdaq GlobeNewswire

The SynBio Innovation Accelerator, a Collaboration between Codexis and Casdin Capital, Enables $10 million Investment in Molecular Assemblies, Inc.

04 ноя 2021 08:00:01 Источник Nasdaq GlobeNewswire

Codexis and Nestlé Health Science Initiate a Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency

03 ноя 2021 16:05:00 Источник Nasdaq GlobeNewswire

Codexis to Report Third Quarter 2021 Financial Results on November 4

21 окт 2021 16:05:00 Источник Nasdaq GlobeNewswire

Codexis, Almelo and RC2 Announce a Tri-Party Collaboration for the Enzymatic Production of Low Cost Sitagliptin API for the Generic Market, Including a License to Codexis Enzyme Technology in India

18 окт 2021 08:00:01 Источник Nasdaq GlobeNewswire

Codexis and Merck Amend and Extend Supply Agreement for Enzyme Used in Manufacture of Sitagliptin

09 сен 2021 16:05:00 Источник Nasdaq GlobeNewswire

Codexis to Participate in Upcoming Virtual Healthcare Conferences

07 сен 2021 16:05:00 Источник Nasdaq GlobeNewswire

Codexis Confirms Receipt of Follow-on Orders for Proprietary Enzyme Product from Undisclosed Global Pharmaceutical Company

25 авг 2021 16:05:00 Источник Nasdaq GlobeNewswire

Codexis Reports Second Quarter 2021 Financial Results

05 авг 2021 16:05:03 Источник Nasdaq GlobeNewswire

Codexis and Kalsec Announce Expanded Collaboration for Supply of Novel Enzyme to Sustainably Produce Natural Clean-Label Beverage Ingredient

02 авг 2021 08:00:01 Источник Nasdaq GlobeNewswire